About Nabros Pharma Private Limited
Data last updated:
Nabros Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1983PTC006628. Its GSTIN is 24AAACN7886N1ZS (Gujarat). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹47.03 Lakh. It is led by directors including Narendrakumar Laxmansingh Darbar (Managing Director) and Kavit Muktikumar Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹101.03 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹57.52 Cr (net margin 56.9%) and EBITDA of ₹66.68 Cr (EBITDA margin 66%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company has about 48 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nabros. As per MCA filings, the company has open charges of ₹45 Lakh on record. Court records list 129 cases involving the company, including 76 filed by the company and 53 filed against it; 5 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2024. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Bueno Salud Care (India) Private Limited with revenue of ₹101.84 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nabros.in.
Company details
CIN history
Nabros Pharma has one previous CIN (Corporate Identification Number): U24230GJ1983PLC006628. The current CIN is U24230GJ1983PTC006628, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1983PTC006628 | Current |
| U24230GJ1983PLC006628 | Previous |
Contact details
Nabros Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is nabros.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor Oriental House – II Opp. Art Gallery, B/H. British Library Law Garden, Ahmedabad, Gujarat, India – 380006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nabros Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nabros Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nabros Pharma Private Limited, buy the company report.
Financials of Nabros Pharma Private Limited
FY 2025 filings availableNabros Pharma Private Limited reported revenue of ₹101.03 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 6% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 66% | ||||
| Net Profit Margin | 56.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nabros Pharma Private Limited, buy the company report.
Board of directors of Nabros Pharma Private Limited
Nabros Pharma has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendrakumar Laxmansingh Darbar Also directs: Syren Healthcare Private Limited | Managing Director | 11 Apr 2024 | 2 Years 6 Months | Current |
| Amit Navnitbhai Shah | Director | 11 Apr 2024 | 2 Years 6 Months | Current |
| Kavit Muktikumar Shah | Whole-Time Director | 05 Apr 2009 | 17 Years 6 Months | Current |
| Chandrikaben Navnitlal Shah Also directs: Nabros Nutriscience LLP, Nabros Securities Private Limited | Whole-Time Director | 29 Oct 1984 | 42 Years 0 Months | Current |
Peer comparison
Nabros Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bueno Salud Care (India) Private Limited | ₹101.84 Cr (FY 2025) | 30.0% | Ahmedabad, Gujarat, India | |||
| Sachin Parenteral Private Limited | ₹101.7 Cr (FY 2025) | 82.0% | Aligarh, Uttar Pradesh, India | |||
| Pharma Impex Laboratories Pvt Ltd | ₹101.54 Cr (FY 2024) | 12.0% | Kolkata, West Bengal, India | |||
| Samrudh Pharmaceuticals Private Limited | ₹101.47 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Nabros Pharma Private Limitedthis company | ₹101.03 Cr (FY 2025) | ₹57.52 Cr | 56.9% | 6.0% | 48 | Ahmedabad, Gujarat, India |
| Instapill Private Limited | ₹100.92 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Sotac Pharmaceuticals Limited | ₹100.88 Cr (FY 2025) | -3.0% | Sanand, Gujarat, India | |||
| Lake Chemicals Private Limited | ₹100.59 Cr (FY 2025) | -5.0% | Bangalore, Karnataka, India | |||
| Credo Life Sciences Private Limited | ₹100.47 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Consern Pharma Limited | ₹100.37 Cr (FY 2025) | -2.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Nabros Pharma Private Limited, buy the company report.
Auditor
Nabros Pharma Private Limited is audited by ATUL B. GANDHI & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL B. GANDHI & Co | FY 2022 | 138500W |
Shareholding
The shareholding of Nabros Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nabros Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 1997 | 90112405 | Canara Bank | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Nabros Pharma Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2024.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Sep 2010 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nabros Pharma Private Limited has 129 court cases on record: 76 filed by Nabros Pharma, 53 filed against it. 5 cases are pending and 124 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 84 | 43 | 0 |
| High courts | 45 | 10 | 5 |
Cases on record (5 of 129)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (TM) | Filed against the company by Lark Laboratories India Ltd. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Lark Laboratories(India) Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Deputy Director, Prohibition and Excise Department and 5 others | Pending |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by Principal Commissioner of Income Tax 3 | Pending |
| Allahabad High Court | Court case (WTAX) | Filed by the company against State of U.P. Thru. Thru. Addl. Chief Secy. Tax and Registration and 3 Others | Disposed |
To see the full case history of Nabros Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nabros Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Narayani Print Industries Private Limited |
To see the full MSME payment records of Nabros Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nabros Pharma Private Limited has a workforce of 48 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
GST
Nabros Pharma has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACN7886N1ZS | Gujarat | Active | 01 Jul 2017 |
| 20AAACN7886N1Z0 | Jharkhand | Active | 01 May 2018 |
| 36AAACN7886N1ZN | Telangana | Active | 01 May 2018 |
| 07AAACN7886N1ZO | Delhi | Active | 19 May 2018 |
To see the full GST registrations and return filing status of Nabros Pharma Private Limited, buy the company report.
Recent activity
Nabros Pharma Private Limited has 11 board changes on record since 1984: 5 appointments and 6 cessations. The latest: Amit Navnitbhai Shah ceased to be Additional Director on 19 Apr 2024.
3 earlier events are in the company report.
Frequently asked questions
Nabros Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 1983 (43+ years old) and is registered under CIN U24230GJ1983PTC006628.
Nabros Pharma has 4 current directors:
- Narendrakumar Laxmansingh Darbar - Managing Director
- Kavit Muktikumar Shah - Whole-Time Director
- Chandrikaben Navnitlal Shah - Whole-Time Director
- Amit Navnitbhai Shah - Director
The latest financial statements of Nabros Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nabros Pharma is 24AAACN7886N1ZS, registered in Gujarat. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 20AAACN7886N1Z0 (Jharkhand), 36AAACN7886N1ZN (Telangana), 07AAACN7886N1ZO (Delhi).
The CIN (Corporate Identification Number) of Nabros Pharma is U24230GJ1983PTC006628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nabros Pharma has 129 court cases on record: 76 filed by the company and 53 filed against it. 5 are pending. Most are in the district courts.
Nabros Pharma was incorporated on 29 December 1983, making it 43+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Nabros Pharma has 2 deals on record (2 secondary share transfers); the latest was in March 2024.
The peers of Nabros Pharma by revenue are Bueno Salud Care (India) Private Limited, Sachin Parenteral Private Limited, Pharma Impex Laboratories Pvt Ltd, Samrudh Pharmaceuticals Private Limited, Instapill Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Navnitbhai Shah ceased to be Additional Director on 19 Apr 2024. Narendrakumar Laxmansingh Darbar ceased to be Additional Director on 19 Apr 2024. Amit Navnitbhai Shah was appointed as Director on 11 Apr 2024. Nabros Pharma has 11 board changes on record in total.
Nabros Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 1 micro and small supplier. The latest return was filed on 03 Jun 2019.
Nabros Pharma can be reached through the website nabros.in. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
